Daping Hospital And The Research Institute Of Surgery Of The Third Military Medical University
Clinical trials sponsored by Daping Hospital And The Research Institute Of Surgery Of The Third Military Medical University, explained in plain language.
-
Robotic surgery showdown: single port vs. multi port for rectal cancer
Disease control Recruiting nowThis study compares two types of robot-assisted surgery for rectal cancer: single-port (one small incision) and multi-port (several incisions). The goal is to see which approach is safer and leads to fewer complications. About 40 adults with stage I to III rectal cancer will take…
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 26, 2026 05:09 UTC
-
New combo therapy aims to boost colon cancer treatment before surgery
Disease control Recruiting nowThis study tests whether adding tolecizumab (a PCSK9 inhibitor) to standard chemoimmunotherapy can better shrink locally advanced colon cancer before surgery. About 106 adults with a specific type of colon cancer will be randomly assigned to receive the combination or chemoimmuno…
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
New breathing method tested to prevent chronic lung disease in preemies
Disease control Recruiting nowThis study compares two types of breathing support (high-frequency oscillation vs. conventional ventilation) in very premature infants with acute respiratory distress syndrome. The goal is to see which method better reduces the risk of chronic lung disease (bronchopulmonary dyspl…
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
Low-dose radiation plus immunotherapy shows promise for liver-limited colorectal cancer
Disease control Recruiting nowThis early-phase trial tests whether adding low-dose radiotherapy to standard immunotherapy and chemotherapy is safe for people with colorectal cancer that has spread only to the liver. About 9 to 18 adults who have not had prior treatment will receive the combination. The main g…
Phase: PHASE1 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New triple therapy aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis study tests whether adding radiation to a mix of chemotherapy and two immunotherapy drugs before surgery can improve outcomes for people with resectable stomach or gastroesophageal junction cancer. About 40 adults with HER2-negative disease will be randomly assigned to recei…
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Brain tumor diagnosis breakthrough: PET/MRI scan spots key mutations Non-Invasively
Diagnosis Recruiting nowThis study tests a special PET/MRI scan that targets IDH mutations, a key genetic marker in gliomas (brain tumors). The goal is to accurately diagnose tumor subtypes and guide treatment without needing a biopsy. Ten adults with suspected or known gliomas will receive the scan to …
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 19, 2026 12:01 UTC